NASDAQ •
Healthcare •
Medical Devices •
Quote as of 07/24/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization23.25 mln
Float53.94 mln
Earnings Date08/06/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.31
Reliable
Relative Strength
30
/ 100
Underperforming
Debt / Equity
13.34
Extremely leveraged
ROE
-137
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 1997 and based in Princeton, New Jersey, Cytosorbents Corporation develops and sells medical devices built around a specialized polymer technology that filters harmful substances from the blood. Its best-known product, CytoSorb, is used in hospital settings to treat serious conditions such as sepsis, organ failure, and complications arising from heart surgery. The company also offers a range of related products targeting drug removal, veterinary care, organ preservation, and blood compatibility, serving customers across the United States, Germany, and other international markets.
